DVA

DaVita Inc
$182.59-$3.15-1.70%Price as of Nov 3, 2026, 9:20 AM ET

Key stats

Market cap
11.5B
Open
—
Day range
—
52-week range
$101.00 – $247.49
Volume
46
Avg volume
780K

Earnings

Q3 FY26Miss
Expected$3.64
Actual$3.40
Q2 FY26
Actual$4.02
Q1 FY26
Actual$2.87
Q4 FY25
Actual$3.29

Next earnings call Feb 1, 2027

About

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Employees
78,000
Headquarters
Denver, CO